IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,464,309 | -4.7% | 55,540 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $2,585,169 | +23.9% | 54,151 | +2.2% | 0.00% | – |
| Q1 2023 | $2,085,747 | +35.2% | 53,005 | -2.8% | 0.00% | – |
| Q4 2022 | $1,542,569 | -8.3% | 54,527 | -2.6% | 0.00% | – |
| Q3 2022 | $1,683,000 | -8.0% | 55,999 | +3.9% | 0.00% | – |
| Q2 2022 | $1,829,000 | -24.0% | 53,875 | +0.4% | 0.00% | – |
| Q1 2022 | $2,408,000 | -14.9% | 53,684 | -12.4% | 0.00% | -100.0% |
| Q4 2021 | $2,831,000 | +37.9% | 61,265 | +0.3% | 0.00% | – |
| Q3 2021 | $2,053,000 | +18.5% | 61,100 | +3.7% | 0.00% | – |
| Q2 2021 | $1,733,000 | +13.9% | 58,928 | -0.1% | 0.00% | – |
| Q1 2021 | $1,521,000 | +12.8% | 59,004 | -0.2% | 0.00% | – |
| Q4 2020 | $1,348,000 | +12.6% | 59,129 | +5.5% | 0.00% | – |
| Q3 2020 | $1,197,000 | -8.4% | 56,032 | -0.5% | 0.00% | – |
| Q2 2020 | $1,307,000 | +11.1% | 56,305 | +2.2% | 0.00% | – |
| Q1 2020 | $1,176,000 | -10.0% | 55,069 | -1.5% | 0.00% | – |
| Q4 2019 | $1,307,000 | +19.5% | 55,892 | +7.4% | 0.00% | – |
| Q3 2019 | $1,094,000 | +10.4% | 52,023 | +7.3% | 0.00% | – |
| Q2 2019 | $991,000 | -3.6% | 48,491 | +32.5% | 0.00% | – |
| Q1 2019 | $1,028,000 | +26.4% | 36,603 | +10.1% | 0.00% | – |
| Q4 2018 | $813,000 | -28.8% | 33,252 | +8.1% | 0.00% | – |
| Q3 2018 | $1,142,000 | +143.5% | 30,749 | +36.1% | 0.00% | – |
| Q2 2018 | $469,000 | +111.3% | 22,588 | +46.4% | 0.00% | – |
| Q1 2018 | $222,000 | -5.1% | 15,432 | 0.0% | 0.00% | – |
| Q4 2017 | $234,000 | +58.1% | 15,432 | 0.0% | 0.00% | – |
| Q3 2017 | $148,000 | +11.3% | 15,432 | 0.0% | 0.00% | – |
| Q2 2017 | $133,000 | -36.7% | 15,432 | -34.8% | 0.00% | – |
| Q1 2017 | $210,000 | -42.8% | 23,661 | -28.5% | 0.00% | – |
| Q4 2016 | $367,000 | -27.6% | 33,094 | +10.9% | 0.00% | – |
| Q3 2016 | $507,000 | +5.6% | 29,837 | +35.2% | 0.00% | – |
| Q2 2016 | $480,000 | +62.2% | 22,065 | +42.9% | 0.00% | – |
| Q1 2016 | $296,000 | +8.8% | 15,439 | +58.6% | 0.00% | – |
| Q4 2015 | $272,000 | +27.1% | 9,734 | +10.6% | 0.00% | – |
| Q3 2015 | $214,000 | – | 8,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |